SCHEMBL5008515

SCHEMBL5008515

C=C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc2cnc(N)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC29A1 Q99808 4/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ ADORA2A P29274 2/20 0.37
▸ ADA P00813 1/20 0.35
▸ LMNA P02545 2/20 0.33
▸ MTOR P42345 2/20 0.33
▸ DNMT1 P26358 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ THPO P40225 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19536251 0.84 ADORA2A (0.53) SLC29A1PDE4DPDE3AADORA2AADA
SCHEMBL731577 0.84 ADORA2A (0.53) SLC29A1PDE4DPDE3AADORA2AADA
SCHEMBL19536253 0.84 ADORA2A (0.53) SLC29A1PDE4DPDE3AADORA2AADA
SCHEMBL474927 0.79 ADK (0.50) ADORA2APRMT5WDR77
SCHEMBL12150829 0.79 ADK (0.50) ADORA2APRMT5WDR77
SCHEMBL12154679 0.79 ADK (0.50) ADORA2APRMT5WDR77
SCHEMBL12300524 0.79 ADK (0.50) ADORA2APRMT5WDR77
SCHEMBL12278609 0.77 PDE3A (0.71) SLC29A1PDE4DPDE3ALMNAMTOR
SCHEMBL21007072 0.76 ADORA2A (0.40) SLC29A1PDE4DPDE3AADORA2AADA
SCHEMBL12154906 0.74 ADORA2A (0.39) ADORA2APRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879607-A2 HCV NS3 PROTEASE INHIBITORS Merck & Co., Inc. (US) 2008-01-23 — — EP disclosed
WO-2006119061-A2 HCV NS3 PROTEASE INHIBITORS MERCK & CO., INC. (US) 2006-11-09 — — WO disclosed
Send feedback